Technology Innovations started in 1999 and created six companies, three of which are public and have over 100 pending or issued patents.

The path taken by a person with an idea, to seeing it actually used as a product or technology, is often a long and difficult one. Many good ideas never get out of the inventor's head, onto paper, and into the market.

One of the companies we founded has developed a medical device for recovering full cardiac output from an arrested heart which is not beating or pumping blood. Over 300,000 people suffer from sudden cardiac arrest in American hospitals each year, and less than 20% of them survive. There is only about 10 minutes available, when a heart stops, to recover it, or the patient will suffer brain damage or death. Our technology installed in minutes is expected to help many of them live and reduce the cost of healthcare.

Making implantable pacemakers, defibrillators and neurostimulators safe with MRI is the mission of another public company we founded. These devices cannot be used safely with MRI today. As an example many people suffer when they cannot get an MRI to check for indications of an early brain tumor, or being staged for a cancer operation. We work with the FDA on establishing ways to measure device safety, and recently signed a deal to sell our MRI safety patent portfolio to Medtronic for $11 million. We anticipate implantable devices in the future will all be made MRI safe as a result of the work we have done. We licensed another technology to Boston Scientific, an investor in this company, for viewing restenosis and clotting of stents and other implantable devices using a nanomagnetic particle thin film coating.

The goal of Technology Innovations is to generate new companies and new intellectual property, and grow the assets and shareholder returns.

Our Scientific Advisory Boards of the companies we have taken public include two Nobel Laureates and two National Medal of Technology recipients.

Our business model generates revenue and profits from licensing and selling of intellectual property, and selling equity in the companies we take public. We are profitable.

When we create a new company around technology, we reach out to private investors to generate the funding needed to move the company to the next step. This is one of the reasons for our participation in the conference. Another is to share the model we have built for investing in and profiting from innovation, including many technologies that have significant potential social benefits, some of which may never get to fruition without a means of improving the harvesting and the yield of ideas in their early stages.